7%, p = 0.1) compared to the infants in the T group, borderline significant to non-significant respectively (Table 3 ).
← all excerpts
Outpatient tapering of buprenorphine in opioid use disorder pregnancies may improve neonatal outcomes.
1
—
—
7%, p = 0.1) compared to the infants in the T group, borderline significant to non-significant respectively (Table 3 ).